XLON
RTW
Market cap38bUSD
Oct 10, Last price
116.00USD
Name
RTW Venture Fund Ltd
Chart & Performance
P/E
1,140.03
P/S
1,006.12
EPS
0.10
Div Yield, %
—
Shrs. gr., 5y
17.81%
Rev. gr., 5y
-0.50%
Revenues
39m
-55.12%
Net income
34m
-58.91%
CFO
-124m
L
Earnings
May 16, 2025
Profile
RTW Venture Fund Limited specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
IPO date
Oct 30, 2019
Employees
Domiciled in
GG
Incorporated in
GG
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | 38,729 -55.12% | 86,296 -336.36% | (36,510) -40.07% | ||||
Cost of revenue | 4,549 | 3,578 | 3,670 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 34,180 | 82,718 | (40,179) | ||||
NOPBT Margin | 88.25% | 95.85% | 110.05% | ||||
Operating Taxes | 83,192 | (4,511) | |||||
Tax Rate | 100.57% | ||||||
NOPAT | 34,180 | (475) | (35,668) | ||||
Net income | 34,180 -58.91% | 83,192 -310.95% | (39,437) -38.71% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 97,080 | (2,093) | |||||
BB yield | 0.01% | ||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | 5,562 | ||||||
Net debt | (726,548) | (385,797) | (378,559) | ||||
| Cash flow | |||||||
Cash from operating activities | (124,338) | 33,541 | 10,354 | ||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | 97,080 | (2,093) | |||||
FCF | 34,180 | 22,161 | (45,779) | ||||
| Balance | |||||||
Cash | 5,360 | 2,722 | 6,966 | ||||
Long term investments | 721,188 | 383,075 | 371,593 | ||||
Excess cash | 724,612 | 381,482 | 380,385 | ||||
Stockholders' equity | 429,023 | 347,924 | |||||
Invested Capital | 760,016 | 64,753 | 53,616 | ||||
ROIC | 8.29% | ||||||
ROCE | 4.50% | 18.54% | |||||
| EV | |||||||
Common stock shares outstanding | 325,460 | 210,635 | 231,981 | ||||
Price | 116.25 9,507.44% | 1.21 -32.02% | |||||
Market cap | 24,486,359 8,623.42% | 280,697 -33.83% | |||||
EV | 24,130,302 | (76,018) | |||||
EBITDA | 34,180 | 82,718 | (40,179) | ||||
EV/EBITDA | 291.72 | 1.89 | |||||
Interest | 4,772 | 1,560 | 780 | ||||
Interest/NOPBT | 13.96% | 1.89% | |||||